Stay updated with breaking news from Project Nextgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In today's Research Roundup for October 2, 2023, we highlight some of the most interesting reads in global health research and development from the past week.
Instead of pouring public funds into private industry—as the U.S. did with COVID-19 vaccines—we must build public capacity and prioritize public objectives.
By Chris Wack Gritstone bio shares were up 17% to $1.39 after the company was awarded a contract valued at up to $433 million by the Biomedical Advanced...
28.09.2023 - Provides Initial $59 Million and up to $168 Million Contingent on MilestonesNATICK, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) - ModeX Therapeutics Inc., an OPKO Health, Inc. company (NASDAQ: OPK), has been awarded a contract from the Biomedical ... Seite 1
-- 10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike plus other viral targets with an approved vaccine against COVID-19 --